RA Capital Healthcare Fund, Director: Janux Therapeutics JANX Buy · Filed 24/10/22

Trade details

Type: Insider buy
Amount: $53,700,000
Shares · price: 1,200,000 sh · $44.75 a share
Held after: 9,317,246 sh
Stock: Janux Therapeutics JANX
Person: RA Capital Healthcare FundDirector
Trade date: 24/10/18
Filed: 24/10/22
Days to filing: 4 days

First buy in 1 years

Since the last buy: 1.3 years
Last buy: 23/07/19
Insiders buying this week: 5 insiders
Holding change: +14.8%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/18~24/11/17

RA Capital Healthcare Fund's recent trades

RA Capital Healthcare FundDirector, 10% Stockholder
Planned saleSionna Therapeutics
Planned sale
Sionna Therapeutics
SION
$21.8M
3,448,811 sh
$21.8M
Filed 09/17
Traded 09/17
RA Capital Healthcare FundDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Healthcare Fund10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17